MedTrace Logo

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

NCT03390894 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2025-05-14

No results posted yet for this study

Summary

This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group.

Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years

Conditions

  • Invasive Breast Cancer Early Stages

Sponsors & Collaborators

  • AECC_Asociación Española contra el Cáncer

    collaborator UNKNOWN

  • Spanish Breast Cancer Research Group

    lead OTHER

Principal Investigators

  • Study Director · Complejo Hospitalario de Especialidades Virgen de la Victoria

  • Study Director · Hospital General Universitario Gregorio Marañón

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2047-01-31
Completion
2048-01-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03390894 on ClinicalTrials.gov